Reply to K. Bujko and D. Tan et al

Comment

Samuel Y Ngan et al. J Clin Oncol. 2013.

. 2013 May 10;31(14):1800-1.

doi: 10.1200/JCO.2012.48.3727.

No abstract available

Comment on

Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04.
Ngan SY, Burmeister B, Fisher RJ, Solomon M, Goldstein D, Joseph D, Ackland SP, Schache D, McClure B, McLachlan SA, McKendrick J, Leong T, Hartopeanu C, Zalcberg J, Mackay J. Ngan SY, et al. J Clin Oncol. 2012 Nov 1;30(31):3827-33. doi: 10.1200/JCO.2012.42.9597. Epub 2012 Sep 24. J Clin Oncol. 2012. PMID: 23008301 Clinical Trial.
But some neoadjuvant schedules are more equal than others.
Tan D, Glynne-Jones R. Tan D, et al. J Clin Oncol. 2013 May 10;31(14):1799-800. doi: 10.1200/JCO.2012.47.7844. Epub 2013 Apr 1. J Clin Oncol. 2013. PMID: 23547080 No abstract available.
Short-course preoperative radiotherapy for low rectal cancer.
Bujko K. Bujko K. J Clin Oncol. 2013 May 10;31(14):1799. doi: 10.1200/JCO.2012.47.3769. Epub 2013 Apr 1. J Clin Oncol. 2013. PMID: 23547083 No abstract available.